Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur

NCT ID: NCT05705726

Last Updated: 2023-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-11

Study Completion Date

2024-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Proximal femur fractures are one of the commonest fractures especially in the elderly population. Early surgical fixation is the best analgesic for associated pain. Spinal anesthesia has been favored by many anesthesiologists due to the simplicity of the technique, the better analgesic profile, and the lower incidence of complications like delirium and thromboembolic events. However, severe pain, encountered during positioning for spinal anesthesia, can complicate the technique and worsen the patient experience.

the study aim to compare the analgesic effect of intravenous dexmedetomidine and fascia iliaca block preoperatively to assist positioning patients for performance of spinal anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

facia iliaca block

Group Type EXPERIMENTAL

ultrasound guided facia iliaca block

Intervention Type DEVICE

Patient will received ultrasound guided fascia iliaca block by 20 ml Bupivacaine 0,25% .

Precedex and ketamine

Group Type EXPERIMENTAL

Intravenous drug

Intervention Type DRUG

Patient will received intravenous injection of precedex 0.25mic/Kg and ketamine 0,2 mg/kg .

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasound guided facia iliaca block

Patient will received ultrasound guided fascia iliaca block by 20 ml Bupivacaine 0,25% .

Intervention Type DEVICE

Intravenous drug

Patient will received intravenous injection of precedex 0.25mic/Kg and ketamine 0,2 mg/kg .

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged 18-60 years.
2. Hip fractures
3. Both sexes.

Exclusion Criteria

1. Patient refusal
2. Allergy to local anesthetics
3. Bleeding diathesis or history of anticoagulant use.
4. impaired cognition or dementia
5. . Infection of the skin at the site of needle punctures area
6. multiple fractures
7. Any previous analgesic administration during the last 12 hours
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hassan Mokhtar Elshorbagy Hetta

lecturer of anesthesia and ICU

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

hassan m. hetta, lecturer

Role: PRINCIPAL_INVESTIGATOR

Minia University, faculty of medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Minia University Hospital

Minya, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

hassan m. hetta, lecturer

Role: CONTACT

1010901114 ext. 0020

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

hassan m. hetta, lecturer

Role: primary

1010901114 ext. 0020

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

524/2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.